Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
21 Oct 2024 |
AA |
Accounts for a dormant company made up to 31 December 2023
|
|
|
17 Oct 2024 |
CS01 |
Confirmation statement made on 5 October 2024 with updates
|
|
|
23 Oct 2023 |
AA |
Accounts for a dormant company made up to 31 December 2022
|
|
|
12 Oct 2023 |
CS01 |
Confirmation statement made on 5 October 2023 with updates
|
|
|
12 Oct 2023 |
PSC05 |
Change of details for Covance Laboratories Limited as a person with significant control on 25 June 2021
|
|
|
04 Jul 2023 |
AP01 |
Appointment of Thomas Kremer as a director on 30 June 2023
|
|
|
30 Jun 2023 |
TM01 |
Termination of appointment of Robert Stewart Pringle as a director on 30 June 2023
|
|
|
06 Oct 2022 |
CS01 |
Confirmation statement made on 5 October 2022 with updates
|
|
|
06 Oct 2022 |
AA |
Accounts for a small company made up to 31 December 2021
|
|
|
19 Apr 2022 |
AA |
Full accounts made up to 31 December 2020
|
|
|
12 Apr 2022 |
TM01 |
Termination of appointment of Stephen Derek Albert Street as a director on 11 April 2022
|
|
|
24 Mar 2022 |
DISS40 |
Compulsory strike-off action has been discontinued
|
|
|
08 Mar 2022 |
GAZ1 |
First Gazette notice for compulsory strike-off
|
|
|
08 Oct 2021 |
CS01 |
Confirmation statement made on 5 October 2021 with updates
|
|
|
09 Sep 2021 |
SH19 |
Statement of capital on 9 September 2021
|
|
|
07 Jan 2021 |
AA |
Full accounts made up to 31 December 2019
|
|
|
22 Dec 2020 |
SH20 |
Statement by Directors
|
|
|
22 Dec 2020 |
CAP-SS |
Solvency Statement dated 11/12/20
|
|
|
22 Dec 2020 |
RESOLUTIONS |
Resolutions
-
RES13 ‐
Share premium account of the company be cancelled in it's entirety 11/12/2020
-
RES06 ‐
Resolution of reduction in issued share capital
|
|
|
05 Oct 2020 |
CS01 |
Confirmation statement made on 5 October 2020 with updates
|
|
|
15 Jun 2020 |
RP04SH01 |
Second filing of a statement of capital following an allotment of shares on 29 May 2019
|
|
|
20 May 2020 |
PSC05 |
Change of details for Covance Laboratories Limited as a person with significant control on 30 October 2019
|
|
|
20 May 2020 |
PSC07 |
Cessation of Laboratory Corporation of America Holdings as a person with significant control on 30 October 2019
|
|
|
20 May 2020 |
PSC07 |
Cessation of Covance Crs, Llc as a person with significant control on 30 October 2019
|
|
|
20 May 2020 |
PSC07 |
Cessation of Andrew Baker as a person with significant control on 30 October 2019
|
|